Antibodies as Drugs
joint with Targeted Cancer Therapies
Organizer(s): James D. Marks, E. Sally Ward and Louis M. WeinerDate: March 27 - April 01, 2009
Location: Whistler Conference Centre, Whistler, BC, Canada
Despite being theorized more than 100 years ago as the “magic bullets” to treat a range of diseases, it is only within the last 10 years that antibodies have become an important class of therapeutics. This meeting will bring together experts from academia and industry to discuss the current state of antibody therapeutics, their mechanism of action in a range of medical indications, novel approaches to improving discovery, manufacturing, formulation, and pharmacokinetics, methods to predict and increase therapeutic efficacy, as well as novel therapeutic opportunities in cancer, infectious diseases, allergy, inflammatory diseases, and the neurosciences. This meeting will be of interest to academic and industry scientists working in all these fields.
Scholarship Deadline: December 1 2008
Discounted Abstract Deadline: December 1 2008
Abstract Deadline: December 29 2008
Discounted Registration Deadline: January 27 2009
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
CovX Research LLC (Pfizer)
Ensemble Discovery Corporation
Seattle Genetics, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: